We analyzed a homogenous set of BC patients excluding patients with breast and ovarian/pancreatic cancer duplicity and patients carrying mutations in non-BRCA1/BRCA2 BC-susceptibility genes. This evidence concerns the gene BRCA1 and pancreatic neoplasm.